GL1X · GenesisL1 explorer

Research workbench

Human estrogen receptor alpha ligand-binding domain in complex with compound 11F

Analyse Human estrogen receptor alpha ligand-binding domain in complex with compound 11F in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2IOG
Type
protein
Length
243 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Estrogen receptor
UniProt
P03372
Ligands
IOG
Pockets
2 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 67% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEstrogen receptorprotein24367% helix, 3% strandP03372

Ligands and binding sites

  • IOG · N-[(1R)-3-(4-hydroxyphenyl)-1-methylpropyl]-2-[2-phenyl-6-(2-piperidin-1-ylethoxy)-1H-indol-3-yl]acetamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13670.830.9238IOG
21070.620.8722empty

Compared structures

  • 2IOG · Human estrogen receptor alpha ligand-binding domain in complex with compound 11F · the same entry in another collection · chain A against A, TM-score 1.00
  • P03372 · AlphaFold monomer V2.0 prediction for estrogen receptor (P03372) · a predicted model of the same protein · chain A against A, TM-score 0.89

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.